Trial lock

This Research is for Members Only

Not a member? Unlock a free sample of our research now!

Already a member?

Sign in now

In Part I, we described the overall approach under the category of AugI, and then focused on recent successes in treating cancer. In Part II, we will shift to related work, still under AugI, in treating autoimmune diseases - a class that has essentially been considered incurable, at least until now.

Related Content

Hide Details

Search Code: 83225
Published: February 14, 2017
Last Revised: February 14, 2017


Get Access

Speak With Representative
Access this content by contacting one of our representatives for assistance.
mark anderson

Mark Anderson

Research Fellow

Mark Anderson writes the most accurate predictive reports covering the computing and communication industries. His weekly Trends and Predictions posts cover must-have information for strategy development and business technology planning, and are followed by technology executives and investors worldwide including Bill Gates, Paul Jacobs, Michael Dell and more.

Download Sample Article